Atlas Trials

MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

Clinical trial NCT02560220 · COMPLETED

Trial details

NCT number
NCT02560220
Sponsor
Heidelberg University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Kidney Failure, Chronic
Start date
2015-08-05
Primary completion
2017-04-18
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.